Specify a stock or a cryptocurrency in the search bar to get a summary
Check Cap Ltd
CHEKCheck-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel. Address: Check-Cap Building, Isfiya, Israel, 3009000
Analytics
WallStreet Target Price
7 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures CHEK
Dividend Analytics CHEK
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CHEK
Stock Valuation CHEK
Financials CHEK
Results | 2019 | Dynamics |